Document is current
Any future updates will be listed below
-
Authors
Mehta, Raaj S.
Mayers, Jared R. https://orcid.org/0000-0002-8607-1787
Zhang, Yancong https://orcid.org/0000-0002-2768-2975
Bhosle, Amrisha
Glasser, Nathaniel R. https://orcid.org/0000-0002-2833-5166
Nguyen, Long H. https://orcid.org/0000-0002-5436-4219
Ma, Wenjie
Bae, Sena
Branck, Tobyn
Song, Kijun https://orcid.org/0000-0002-6037-9345
Sebastian, Luke
Pacheco, Julian Avila https://orcid.org/0000-0001-9388-3946
Seo, Hyuk-Soo https://orcid.org/0000-0003-0646-2102
Clish, Clary https://orcid.org/0000-0001-8259-9245
Dhe-Paganon, Sirano https://orcid.org/0000-0003-0824-5929
Ananthakrishnan, Ashwin N.
Franzosa, Eric A. https://orcid.org/0000-0002-8798-7068
Balskus, Emily P. https://orcid.org/0000-0001-5985-5714
Chan, Andrew T.
Huttenhower, Curtis https://orcid.org/0000-0002-1110-0096
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R24 DK110499-01A1, T32HL008633-36, 1K23DK125838, P30 GM124165, R35 CA253185)
American College of Gastroenterology (Pilot Award)
National Science Foundation
American Gastroenterological Association
Doris Duke Charitable Foundation (DDCF
Linde Family Foundation Novartis Institute for Biomedical Research
Howard Hughes Medical Institute
Pfizer Ulcerative Colitis Grant
- License Information
-
More Information
Article History
Received: 15 April 2022
Accepted: 10 January 2023
First Online: 23 February 2023
Competing interests
: C.H. is a consultant to Zoe, Ltd. and is on the scientific advisory boards of Seres Therapeutics and Empress Therapeutics. A.T.C. has been an investigator on a clinical study supported by Zoe, Ltd. Other authors declare that they have no competing interests. R.S.M., J.R.M., E.P.B., A.T.C. and C.H. filed a provisional patent application (63/383,269) on 11 November 2022.
